SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Youssef, F.
Right arrow Articles by Hamilton, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Youssef, F.
Right arrow Articles by Hamilton, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Effect of Short-Term Treatment with Simvastatin on Renal Function in Patients with Peripheral Arterial Disease

Fahed Youssef, FRCS

University Department of Surgery, Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

Prakash Gupta, MB, BS

University Department of Surgery, Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

Alexander M. Seifalian, PhD

University Department of Surgery, Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

Fiona Myint, FRCS

University Department of Surgery, Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

Dimitri P. Mikhailidis, FRCPath, FACA

Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

George Hamilton, FRCS

University Department of Surgery, Department of Clinical Biochemistry, Royal Free Hospital NHS Trust and Royal Free and University College Medical School, London, United Kingdom.

The objective of this study was to investigate the effects of lipid-lowering treatment on renal function in patients with peripheral arterial disease (PAD). This was a retrospective study of hyperlipidemic claudicants referred to a vascular surgery and risk modification clinic. Serum creatinine and urate concentrations and the fasting lipid profile were measured pretreatment and after 3-4 months of treatment with 20 mg/day simvastatin. In 103 consecutive patients with PAD (57 men; 46 women), median age 67 years (range: 51 to 83) there was a significant decrease in serum creatinine from a mean (SD) of 87 (12) µmol/L pretreatment to 84 (12) µmol/L post-treatment (p<0.0001). This difference was more marked in the tertile of patients with the highest baseline creatinine levels. There was also a significant reduction in serum urate from 0.37 (0.07) mmol/L to 0.35 (0.07) mmol/L (p<0.0001). Both these effects were independent of the degree of total cholesterol (TC) or low-density lipoprotein (LDL) cholesterol reduction. There was a significant reduction in TC from 6.6 (1.0) to 5.2 (0.8) mmol/L and LDL cholesterol from 4.3 (1.0) to 2.8 (0.7) mmol/L; both p<0.0001. Significant improvement also occurred in the high-density lipoprotein cholesterol and triglyceride levels. Cholesterol lowering with simvas tatin 20 mg/day improved indices of renal function after 3-4 months of treatment in hyper lipidemic patients with PAD. Further studies are needed to establish and define the clinical relevance of these findings, especially in patients with different degrees of renal failure.

Angiology, Vol. 55, No. 1, 53-62 (2004)
DOI: 10.1177/000331970405500108


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
K. I. Paraskevas, N. Bessias, J. Tzorbatzoglou, D. P. Mikhailidis, and V. Andrikopoulos
Effect of Statins on Renal Function in Patients With Peripheral Arterial Disease
Vascular and Endovascular Surgery, December 1, 2009; 42(6): 620 - 621.
[PDF]


Home page
ANGIOLOGYHome page
K. I. Paraskevas, T. T. Papas, P. Pavlidis, N. Bessias, and V. Andrikopoulos
The Importance of Conservative Measures in Peripheral Arterial Disease: An Update
Angiology, October 1, 2008; 59(5): 529 - 533.
[PDF]


Home page
ANGIOLOGYHome page
K. I. Paraskevas, N. Bessias, T. T. Papas, C. D. Gekas, V. Andrikopoulos, and D. P. Mikhailidis
Do Different Vascular Risk Factors Affect All Arteries Equally?
Angiology, August 1, 2008; 59(4): 397 - 401.
[Abstract] [PDF]



Advertisement